Ads
related to: biotechnology
Search results
Why Is Infectious Disease-Focused Vir Biotechnology Stock Trading Higher On Wednesday?
Benzinga· 1 day agoOn Wednesday, Vir Biotechnology Inc VIR announced new preliminary data from its Phase 2 SOLSTICE hepatitis delta clinical trial evaluating tobevibart and elebsiran for chronic ...
Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in...
Benzinga· 3 days agoPuma Biotechnology, Inc. PBYI, a biopharmaceutical company, announced the presentation of alisertib for the treatment of patients with advanced osimertinib-resistant epidermal ...
Jonesboro-based GreenLab expands research on corn | Arkansas Democrat Gazette
Arkansas Democrat-Gazette· 5 days agoGreenLab, a Jonesboro-based biotechnology startup, has developed technology to grow proteins in corn...
Why biotech's big convention isn't returning to San Francisco. (Hint: It has nothing to do with a...
The Business Journals· 16 hours agoInstead, said BIO CEO John Crowley, BIO has contracts in San Diego, where 19,000 attendees this week...
Why Is Virax Biolabs (VRAX) Stock Up 115% Today?
InvestorPlace· 17 hours agoVirax Biolabs (NASDAQ:VRAX) stock is rocketing higher on Thursday morning alongside heavy pre-market trading of the biotechnology company’s shares. The...
Indaptus reports positive Phase 1 trial results for cancer treatment By Investing.com
Investing.com· 3 days agoIndaptus Therapeutics, Inc. (NASDAQ: INDP), a biotechnology firm focused on developing therapies for...
I-Mab and Bristol Myers team up for cancer drug trial By Investing.com
Investing.com· 1 day agoI-Mab (NASDAQ: IMAB), a biotechnology firm specializing in cancer immunotherapies, has announced a...
GSK, after 11-month romance, buys oligonucleotide partner Elsie for up to $50M
FierceBiotech· 15 hours agoAfter taking 11 months to get to know Elsie Biotechnologies' oligonucleotide platform, GSK is ready...
Top Growth Companies With High Insider Ownership On Chinese Exchanges In June 2024
Simply Wall St. via Yahoo Finance· 6 hours agoAs of June 2024, Chinese equities have shown resilience amidst global economic fluctuations, with...
Adicet Bio gains FDA Fast Track for lupus nephritis treatment By Investing.com
Investing.com· 1 day agoREDWOOD CITY, Calif. & BOSTON - Adicet Bio, Inc. (NASDAQ: ACET), a biotechnology firm in the...